Posted 01 September, 2023
NUVASIVE INC appointed new CEO
CEO Change detected for ticker Nasdaq:NUVA in a 8-K filed on 01 September, 2023.
In connection with the consummation of the Merger and pursuant to the terms of the Merger Agreement, at the Effective Time and in connection with NuVasive becoming a subsidiary of Globus Medical: (i) J. Christopher Barry and Matthew K. Harbaugh ceased to be, respectively, the chief executive officer and the chief financial officer and principal accounting officer of NuVasive, (ii) each of Michael Farrington, Nathaniel B. Sisitsky and Dale Wolf ceased to be senior vice presidents of NuVasive, and (iii) Daniel Scavilla, Merger Sub's Chief Executive Officer immediately prior to the Effective Time, Kelly Huller, Merger Sub's Corporate Secretary immediately prior to the Effective Time, and Keith Pfeil, Merger Sub's Chief Financial Officer immediately prior to the Effective Time, became, respectively, the chief executive officer, corporate secretary and chief financial officer of NuVasive.
N/A
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. In connection with the consummation of the Merger and pursuant to the terms of the Merger Agreement, all of the members of the NuVasive Board immediately prior to the Effective Time ceased to be directors of NuVasive at the Effective Time and Daniel Scavilla and Keith Pfeil, each a director of Merger Sub immediately prior to the Effective Time, became a director of NuVasive. In connection with the consummation of the Merger and pursuant to the terms of the Merger Agreement, at the Effective Time and in connection with NuVasive becoming a subsidiary of Globus Medical: (i) J. Christopher Barry and Matthew K. Harbaugh ceased to be, respectively, the chief executive officer and the chief financial officer and principal accounting officer of NuVasive, (ii) each of Michael Farrington, Nathaniel B. Sisitsky and Dale Wolf ceased to be senior vice presidents of NuVasive, and (iii) Daniel Scavilla, Merger Sub's Chief Executive Officer immediately prior to the Effective Time, Kelly Huller, Merger Sub's Corporate Secretary immediately prior to the Effective Time, and Keith Pfeil, Merger Sub's Chief Financial Officer immediately prior to the Effective Time, became, respectively, the chief executive officer, corporate secretary and chief financial officer of NuVasive. -4- In addition, effective as of the Effective Time, the NuVasive, Inc. Deferred Compensation Plan was terminated. The information set forth in the Introductory Note and Item 2.01 is incorporated herein by reference into this Item 5.02.
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.